Acebutolol Hydrochloride Capsule
Product Images NDC 53746-669

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 53746-669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F1931f84-figure-01 (Acebutolol HCl Capsules Usp India 1)

FDA Label Image

F1931f84-figure-02 (Acebutolol HCl Capsules Usp India 2)

F1931f84-figure-02 (Acebutolol HCl Capsules Usp   India 2)
This is a table showing adverse reactions reported in a study of Acebutolol, Propranolol, Hydrochlorothiazide and Placebo. The study involved 1002 participants, and the table shows the percentage of each group reporting a particular symptom. The symptoms are grouped by body system such as Cardiovascular, Central Nervous System, etc. The symptoms reported include Chest Pain, Edema, Depression, Dizziness, Fatigue, Headache, Rash, Constipation, Diarrhea, and more.*
FDA Label Image

F1931f84-figure-03 (Acebutolol HCl Capsules Usp India 3)

F1931f84-figure-03 (Acebutolol HCl Capsules Usp   India 3)
This appears to be a medical report detailing the dosage of medication for a patient along with a breakdown of how the medication may impact different systems within the body. The medication dosage is given in milligrams per day and ranges from 500 to 1200 mg/day. The report also lists different body systems and assigns a letter grade to indicate the potential impact of the medication on each system. The systems evaluated include cardiovascular, gastrointestinal, musculoskeletal, central nervous, respiratory, skin, special senses, and urinary. However, without further context, it is difficult to provide a more detailed description of the report's contents.*
FDA Label Image

1 (Acebutolol HCl Capsules Usp India 4)

1 (Acebutolol HCl Capsules Usp   India 4)
Acebutolol Hydrochloride Capsules, USP is a Rx medicine containing 100 capsules and each capsule consists of Acebutolol hydrochloride, USP equivalent to 200 mg of acebutolol. The drug should be kept away from the reach of children and should be kept tightly closed. The medicine should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and protected from light. The manufacturer, Amneal Pharmaceuticals Pvt. Ltd. is located in Ahmedabad, India, but the medicine is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The text also includes additional information such as the NDC number and the usual adult dosage information available in the package insert.*
FDA Label Image

1 (Acebutolol HCl Capsules Usp India 5)

1 (Acebutolol HCl Capsules Usp   India 5)
This is a description of Acebutolol Hydrochloride Capsules, used as medication for adults. Each capsule contains 400mg of Acebutolol hydrochloride, and it needs to be stored away from children in a tightly closed, light-resistant container. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, while distribution is by Amneal Pharmaceuticals LLC in Bridgewater, NJ. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.